The Design Driver for Biosimilar Adoption

Pharmaceutical Technology Europe provides readers with useful technical information to assist them in their drug development work. The website and magazine cover technologies, strategies, and regulations crucial to professionals developing and manufacturing pharmaceuticals and biopharmaceuticals for the European market and beyond.

George I’ons, Head of Product Strategy and Insights at Owen Mumford Pharmaceutical Services’ discusses the impact of device design as a driver in the fast growing global market of biosimilars, now valued at $3.12 billion per year.